Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. articles
  3. covid 19 and influenza simultaneous detection
Show results for
News

Refine by
Date

  • Older

Covid 19 And Influenza Simultaneous Detection Articles & Analysis

4 articles found

qPCR for SARS-CoV-2 Detection and Research: Introduction, Principles, and Applications

qPCR for SARS-CoV-2 Detection and Research: Introduction, Principles, and Applications

Introduction to Quantitative Polymerase Chain Reaction A highly delicate technique for the amplification and identification of deoxyribonucleic acid is polymerase chain reaction (PCR). In molecular biology, its conceptual simplification has made it the most utilized method and can, in theory, identify as little as a single segment of DNA. Therefore, for a huge variety of bacterial, fungal, viral, ...

ByCD Genomics


Airborne SARS CoV-2 detection allows for adaptive mitigation of virus - Case Stduy

Airborne SARS CoV-2 detection allows for adaptive mitigation of virus - Case Stduy

The University of Maryland, Baltimore County uses Smiths Detection’s Bioflash Biological Identifier to help confirm presence of virus in the air allowing for real time response to covid-19. Stop the Spread of Covid-19 At the start of the COVID-19 pandemic, Smiths Detection’s team based at its Biotechnology Center of Excellence in Baltimore, MD, began developing a new capability to ...

BySmiths Detection Inc.


Smell tester for early detection of increasing Covid-19 infections

Smell tester for early detection of increasing Covid-19 infections

Functional principle The smell tester is measuring association velocity by using stable concentration profile of odor. Because of this the odor recognition is only dependent on the amount of available odor receptors. Changes in smell is a prominent symptom of COVID-19, as has consistently been demonstrated in many countries. By using the odor tester on patients, we could quickly detect COVID-19 ...

ByGenius5-Instruments GmbH


Nanostics is Developing and Validating a Simple Blood Test to Predict Severity of COVID-19 Disease in SARS-CoV-2 Positive Patients

Nanostics is Developing and Validating a Simple Blood Test to Predict Severity of COVID-19 Disease in SARS-CoV-2 Positive Patients

Edmonton, Alberta - Nanostics Inc., a diagnostic healthcare company that focuses on developing tests to determine a patient's disease risk, announced today plans to develop and validate ClarityDX COVID-19; a simple blood test to predict the severity of COVID-19 disease in patients. Nanostics, in collaboration with the Canadian BioSample Repository (CBSR) at the University of Alberta and Century ...

ByNanostics Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Industry Products
  • Medical Industry Software
  • Medical Industry Training
  • Medical Industry Services
  • Medical Industry Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles
  • Medical Industry Books
  • Medical Industry Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT